Immunovant (IMVT) Retained Earnings (2018 - 2026)
Immunovant (IMVT) recorded Retained Earnings of -$1.9 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$1.36 billion a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Retained Earnings (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Retained Earnings of -$1.75 billion.
- Across earlier fiscal years, Retained Earnings came in at -$1.24 billion in FY2025, -$825.68 million in FY2024, -$566.35 million in FY2023 and -$355.39 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Retained Earnings in data going back to fiscal Q3 2019.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.75 billion (Q4 2026), -$1.6 billion (Q3 2026) and -$1.49 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 37.97 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 168.36 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -16.19 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 66.22 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 12.59 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -19.81 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.11 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 115.33 Bn |
| 10 | Immunovant | 7.32 Bn | 4.11 Bn | - | -1.90 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.90 Bn |
| Mar 31, 2026 | -1.75 Bn |
| Dec 31, 2025 | -1.60 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Jun 30, 2025 | -1.36 Bn |
| Mar 31, 2025 | -1.24 Bn |
| Dec 31, 2024 | -1.13 Bn |
| Sep 30, 2024 | -1.02 Bn |
| Jun 30, 2024 | -912.83 Mn |
| Mar 31, 2024 | -825.68 Mn |
| Dec 31, 2023 | -750.40 Mn |
| Sep 30, 2023 | -698.95 Mn |
| Jun 30, 2023 | -640.30 Mn |
| Mar 31, 2023 | -566.35 Mn |
| Dec 31, 2022 | -506.92 Mn |
| Sep 30, 2022 | -443.70 Mn |
| Jun 30, 2022 | -395.80 Mn |
| Mar 31, 2022 | -355.39 Mn |
| Dec 31, 2021 | -308.22 Mn |
| Sep 30, 2021 | -266.83 Mn |
API Access
Immunovant Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();